The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
Abstract
Angiotensin (Ang)-(1–7) is now recognized as a biologically active component of the renin–angiotensin system (RAS). Ang-(1–7) appears to play a central role in the RAS because it exerts a vast array of actions, many of them opposite to those attributed to the main effector peptide of the RAS, Ang II. The discovery of the Ang-converting enzyme (ACE) homolog ACE2 brought to light an important metabolic pathway responsible for Ang-(1–7) synthesis. This enzyme can form Ang-(1–7) from Ang II or less efficiently through hydrolysis of Ang I to Ang-(1–9) with subsequent Ang-(1–7) formation by ACE. In addition, it is now well established that the G protein-coupled receptor Mas is a functional binding site for Ang-(1–7). Thus, the axis formed by ACE2/Ang-(1–7)/Mas appears to represent an endogenous counterregulatory pathway within the RAS, the actions of which are in opposition to the vasoconstrictor/proliferative arm of the RAS consisting of ACE, Ang II, and AT 1 receptor. In this brief review, we will discuss recent findings related to the biological role of the ACE2/Ang-(1–7)/Mas arm in the cardiovascular and renal systems, as well as in metabolism. In addition, we will highlight the potential interactions of Ang-(1–7) and Mas with AT 1 and AT 2 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Self-citationAngiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733 · cited 2×
“Most of these observations are corroborated by data obtained with ACE2-deficient mice (Crackower et al. 2002, Yamamoto et al. 2006, Jin et al. 2012).”
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000251865.35728.2f · Cited by 562
Ramipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541
Drugs targeting the renin–angiotensin–aldosterone system
Zaman, M. A., Oparil, S., & Calhoun, D. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd873 · Cited by 439
Myocardial infarction increases ACE2 expression in rat and humans
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160867.23556.7d · Cited by 415
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
The Cardiac Renin-Angiotensin System: Conceptual, or a Regulator of Cardiac Function?
Dostal, D. E., & Baker, K. M. (1999) · Circulation Research · doi:10.1161/01.res.85.7.643 · Cited by 398
Santos, R. A. S., Campagnole-Santos, M. J., & Andrade, S. P. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00138-5 · Cited by 380
Self-citationTissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
Self-citationACE and ACE2 Activity in Diabetic Mice
Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S., & Batlle, D. (2006) · Diabetes · doi:10.2337/db06-0033 · Cited by 339
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci16980 · Cited by 334
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)
Grobe, J. L., Mecca, A. P., Lingis, M., Shenoy, V., Bolton, T. A., Machado, J. M., Speth, R. C., Raizada, M. K., & Katovich, M. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00937.2006 · Cited by 332
Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., et al. (2010) · Diabetes · doi:10.2337/db09-1218 · Cited by 300
Metabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
Chappell, M. C., Pirro, N. T., Sykes, A., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.362 · Cited by 289
Schiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationSantos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Self-citationAngiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Sampaio, W. O., Henrique de Castro, C., Santos, R. A. S., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.084848 · Cited by 283
Self-citationOcaranza, M. P., Godoy, I., Jalil, J. E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000237862.94083.45 · Cited by 273
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
Remuzzi, G., Ruggenenti, P., & Perico, N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00010 · Cited by 272
Hernández Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A. S., Castellano, R. K., Lampkins, A. J., Gubala, V., Ostrov, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108944 · Cited by 271
Self-citationFerrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Santos, R. A. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01274 · Cited by 259
Self-citationLi, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.394 · Cited by 246
Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241
Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism
Santos, S. H. S., Fernandes, L. R., Mario, E. G., Ferreira, A. V. M., Pôrto, L. C. J., Alvarez-Leite, J. I., Botion, L. M., Bader, M., Alenina, N., & Santos, R. A. S. (2008) · Diabetes · doi:10.2337/db07-0953 · Cited by 241
Self-citationAngiotensin-(1-7): Cardioprotective Effect in Myocardial Ischemia/Reperfusion
Ferreira, A. J., Santos, R. A. S., & Almeida, A. P. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.665 · Cited by 240
Self-citationPörsti, I., Bara, A. T., Busse, R., & Hecker, M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14787.x · Cited by 239
Huentelman, M. J., Grobe, J. L., Vazquez, J., Stewart, J. M., Mecca, A. P., Katovich, M. J., Ferrario, C. M., & Raizada, M. K. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.031096 · Cited by 237
Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
Santos, R. A. S., Castro, C. H., Gava, E., Pinheiro, S. V. B., Almeida, A. P., de Paula, R. D., Cruz, J. S., Ramos, A. S., Rosa, K. T., Irigoyen, M. C., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000215289.51180.5c · Cited by 237
Self-citationZhong, J., Guo, D., Chen, C. B., Wang, W., Schuster, M., Loibner, H., Penninger, J. M., Scholey, J. W., Kassiri, Z., & Oudit, G. Y. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164244 · Cited by 233
Oudit, G. Y., Herzenberg, A. M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., Crackower, M. A., Backx, P. H., Penninger, J. M., & Scholey, J. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051091 · Cited by 232
ACE2 gene expression is up-regulated in the human failing heart
Goulter, A. B., Goddard, M. J., Allen, J. C., & Clark, K. L. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-19 · Cited by 231
Iwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles
Ren, Y., Garvin, J. L., & Carretero, O. A. (2002) · Hypertension · doi:10.1161/hy0302.104673 · Cited by 223
Chronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Grobe, J. L., Mecca, A. P., Mao, H., & Katovich, M. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01170.2005 · Cited by 222
Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y., & Batlle, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002373 · Cited by 217
Donoghue, M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00177-9 · Cited by 214
Identification of angiotensin-(1-7) in rat brain
Chappell, M. C., Brosnihan, K. B., Diz, D. I., & Ferrario, C. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84737-3 · Cited by 213
Angiotensin-(1-7)–Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells
Heitsch, H., Brovkovych, S., Malinski, T., & Wiemer, G. (2001) · Hypertension · doi:10.1161/01.hyp.37.1.72 · Cited by 208
Walters, P. E., Gaspari, T. A., & Widdop, R. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000160325.59323.b8 · Cited by 206
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
Gupte, M., Boustany-Kari, C. M., Bharadwaj, K., Police, S., Thatcher, S., Gong, M. C., English, V. L., & Cassis, L. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00183.2008 · Cited by 204
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Díez-Freire, C., Vázquez, J., Correa de Adjounian, M. F., Ferrari, M. F. R., Yuan, L., Silver, X., Torres, R., & Raizada, M. K. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00312.2005 · Cited by 200
Azizi, M., & Ménard, J. (2004) · Circulation · doi:10.1161/01.cir.0000131449.94713.ad · Cited by 199
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000037979.53963.8f · Cited by 199
Su, Z., Zimpelmann, J., & Burns, K. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001509 · Cited by 196
Bindom, S. M., Hans, C. P., Xia, H., Boulares, A. H., & Lazartigues, E. (2010) · Diabetes · doi:10.2337/db09-0782 · Cited by 196
Systemic and regional hemodynamic effects of angiotensin-(1–7) in rats
Sampaio, W. O., Nascimento, A. A. S., & Santos, R. A. S. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01145.2002 · Cited by 191
Self-citationEndothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice
Xu, P., Costa-Goncalves, A. C., Todiras, M., Rabelo, L. A., Sampaio, W. O., Moura, M. M., Sousa Santos, S., Luft, F. C., Bader, M., Gross, V., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102764 · Cited by 191
Self-citationAngiotensin-(1–7) Is a Modulator of the Human Renin-Angiotensin System
Roks, A. J. M., van Geel, P. P., Pinto, Y. M., Buikema, H., Henning, R. H., de Zeeuw, D., & van Gilst, W. H. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.296 · Cited by 190
Benter, I. F., Yousif, M. H. M., Anim, J. T., Cojocel, C., & Diz, D. I. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2005 · Cited by 187
Santos, R. A. S., Ferreira, A. J., Nadu, A. P., Braga, A. N. G., de Almeida, A. P., Campagnole-Santos, M. J., Baltatu, O., Iliescu, R., Reudelhuber, T. L., & Bader, M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00227.2003 · Cited by 187
Self-citationConverting enzyme activity and angiotensin metabolism in the dog brainstem.
Santos, R. A., Brosnihan, K. B., Chappell, M. C., Pesquero, J., Chernicky, C. L., Greene, L. J., & Ferrario, C. M. (1988) · Hypertension · doi:10.1161/01.hyp.11.2_pt_2.i153 · Cited by 186
Self-citationGallagher, P. E., Chappell, M. C., Ferrario, C. M., & Tallant, E. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00409.2004 · Cited by 185
Jayasooriya, A. P., Mathai, M. L., Walker, L. L., Begg, D. P., Denton, D. A., Cameron-Smith, D., Egan, G. F., McKinley, M. J., Rodger, P. D., Sinclair, A. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802690105 · Cited by 185
Muthalif, M. M., Benter, I. F., Uddin, M. R., Harper, J. L., & Malik, K. U. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37208-8 · Cited by 175
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175
Self-citationDifferential baroreceptor reflex modulation by centrally infused angiotensin peptides
Campagnole‐Santos, M. J., Heringer, S. B., Batista, E., Khosla, M. C., & Santos, R. A. S. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.263.1.r89 · Cited by 171
Self-citationCardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats
Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., & Ferrario, C. M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.1.h324 · Cited by 171
Self-citationGiani, J. F., Mayer, M. A., Muñoz, M. C., Silberman, E. A., Höcht, C., Taira, C. A., Gironacci, M. M., Turyn, D., & Dominici, F. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90678.2008 · Cited by 170
Renal actions of angiotensin-(1-7): in vivo and in vitro studies
Handa, R. K., Ferrario, C. M., & Strandhoy, J. W. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.1.f141 · Cited by 169
de Castro, C. H., Souza dos Santos, R. A., Ferreira, A. J., Bader, M., Alenina, N., & Pinto de Almeida, A. (2005) · Hypertension · doi:10.1161/01.hyp.0000175813.04375.8a · Cited by 168
Self-citationAngiotensin-(1–7) and the renin–angiotensin system
Santos, R. A., & Ferreira, A. J. (2007) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e328031f362 · Cited by 167
Self-citationMolecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Tallant, E. A., & Clark, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000090322.55782.30 · Cited by 167
Kingston, R. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00006 · Cited by 166
Cardiovascular actions of angiotensin-(1-7)
Ferreira, A. J., & Santos, R. A. S. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000400003 · Cited by 165
Self-citationMolecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
Dias-Peixoto, M. F., Santos, R. A. S., Gomes, E. R. M., Alves, M. N. M., Almeida, P. W. M., Greco, L., Rosa, M., Fauler, B., Bader, M., Alenina, N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114280 · Cited by 163
Self-citationSantos, S. H. S., Braga, J. F., Mario, E. G., Pôrto, L. C. J., Rodrigues-Machado, M. D. G., Murari, A., Botion, L. M., Alenina, N., Bader, M., & Santos, R. A. S. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200493 · Cited by 162
Self-citationAngiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats
Paula, R. D., Lima, C. V., Khosla, M. C., & Santos, R. A. S. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.1154 · Cited by 160
Self-citationEvidence for a local renin angiotensin system in primary cultured human preadipocytes
Schling, P., Mallow, H., Trindl, A., & Löffler, G. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800821 · Cited by 158
The renin–angiotensin and the kallikrein–kinin systems
Campbell, D. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00262-5 · Cited by 157
Pinheiro, S. V. B., Ferreira, A. J., Kitten, G. T., da Silveira, K. D., da Silva, D. A., Santos, S. H. S., Gava, E., Castro, C. H., Magalhães, J. A., da Mota, R. K., et al. (2009) · Kidney International · doi:10.1038/ki.2009.61 · Cited by 157
Self-citationMenon, J., Soto‐Pantoja, D. R., Callahan, M. F., Cline, J. M., Ferrario, C. M., Tallant, E. A., & Gallagher, P. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3614 · Cited by 155
Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A., & Burns, K. D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00144.2004 · Cited by 155
Furuhashi, M., Ura, N., Takizawa, H., Yoshida, D., Moniwa, N., Murakami, H., Higashiura, K., & Shimamoto, K. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00021 · Cited by 155
Production of angiotensin-(1-7) by human vascular endothelium.
Santos, R. A. S., Brosnihan, K. B., Jacobsen, D. W., DiCorleto, P. E., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii56 · Cited by 151
Self-citationMarques, F. D., Ferreira, A. J., Sinisterra, R. D., Jacoby, B. A., Sousa, F. B. D., Caliari, M. V., Silva, G. A. B., Melo, M. B., Nadu, A. P., de Souza, L. E., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167346 · Cited by 148
Self-citationDifferential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds
Osei, S. Y., Ahima, R. S., Minkes, R. K., Weaver, J. P., Khosla, M. C., & Kadowitz, P. J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90703-k · Cited by 147
The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets
Fraga-Silva, R. A., Pinheiro, S. V. B., Gonçalves, A. C. D. C., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2008) · Molecular Medicine · doi:10.2119/2007-00073.fraga-silva · Cited by 146
Self-citationIntrarenal Renin Angiotensin System Revisited
Pohl, M., Kaminski, H. J., Castrop, H., Bäder, M., Himmerkus, N., Bleich, M., Bachmann, S., & Theilig, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150284 · Cited by 143
Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissues
Metzger, R., Bäder, M., Ludwig, T., Berberich, C. E., Bunnemann, B., & Ganten, D. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01292-9 · Cited by 143
Genetically altered animal models for Mas and angiotensin‐(1–7)
Alenina, N. V., Xu, P., Rentzsch, B., Patkin, E. L., & Bäder, M. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.040345 · Cited by 142
Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation
Esteban, V., Heringer‐Walther, S., Sterner‐Kock, A., de Bruin, R., van den Engel, S., Wang, Y., Mezzano, S. A., Egido, J., Schultheiss, H., Ruiz‐Ortega, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005406 · Cited by 141
Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs
Santos, R. A. S., Ferreira, A. J., Pinheiro, S. V. B., Sampaio, W. O., Touyz, R. M., & Campagnole‐Santos, M. J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.8.1019 · Cited by 132
Self-citationCardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
Averill, D. B., Ishiyama, Y., Chappell, M. C., & Ferrario, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000092888.63239.54 · Cited by 132
What?s new in the renin-angiotensin system? Novel angiotensin peptides
Ferrario, C. M., & Chappell, M. C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4243-4 · Cited by 131
Savergnini, S. Q., Beiman, M., Lautner, R. Q., de Paula, V., Allahdadi, K. J., Pessoa, D. C., Costa-Fraga, F. P., Fraga-Silva, R. A., Cojocaru, G., Cohen, Y., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.152942 · Cited by 130
Self-citationFernandes, L., Fortes, Z. B., Nigro, D., Tostes, R. C., Santos, R. A. S., & de Carvalho, M. H. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.703 · Cited by 129
Self-citationLemos, V. S., Silva, D. M. R., Walther, T., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000175237.41573.63 · Cited by 128
Self-citationFerreira, A. J., Jacoby, B. A., Araújo, C. A. A., Macedo, F. A. F. F., Silva, G. A. B., Almeida, A. P., Caliari, M. V., & Santos, R. A. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00828.2006 · Cited by 127
Self-citationLiu, C. X., Hu, Q., Wang, Y., Zhang, W., Ma, Z. Y., Feng, J. B., Wang, R., Wang, X. P., Dong, B., Gao, F., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00111 · Cited by 127
Gomes, E. R. D. M., Lara, A., Almeida, P., Guimarães, D., Resende, R. R., Campagnole‐Santos, M. J., Bäder, M., Santos, R. A. S., & Guatimosim, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.143255 · Cited by 122
Self-citationEffect of ACE2 and angiotensin-(1–7) in a mouse model of early chronic kidney disease
Dilauro, M., Zimpelmann, J., Robertson, S. J., Genest, D. S., & Burns, K. D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00426.2009 · Cited by 120
Giani, J. F., Gironacci, M. M., Muñoz, M. C., Peña, C., Turyn, D., & Dominici, F. P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01395.2006 · Cited by 119
Nadarajah, R., Milagres, R., Dilauro, M., Gutsol, A. A., Xiao, F., Zimpelmann, J., Kennedy, C., Wysocki, J. A., BATLLE, D. C., & Burns, K. D. (2012) · Kidney International · doi:10.1038/ki.2012.83 · Cited by 116
Kim, S.-M., Kim, Y., Jeong, K.-H., Lee, S. H., Lee, T., Ihm, C., & Moon, J.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039739 · Cited by 115
Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
Garcia, N. H., & Garvin, J. L. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v541133 · Cited by 115
Synergistic effect of angiotensin-(1–7) on bradykinin arteriolar dilation in vivo
Oliveira, M. A., Fortes, Z. B., Santos, R. A. S., Koshla, M. C., & de Carvalho, M. H. C. (1999) · Peptides · doi:10.1016/s0196-9781(99)00123-0 · Cited by 114
Self-citationAngiotensin-(1–7) in kidney disease: a review of the controversies
Zimmerman, D. L., & Burns, K. D. (2012) · Clinical Science · doi:10.1042/cs20120111 · Cited by 114
Angiotensin-(1-7) Formation in the Intact Human Heart
Zisman, L. S., Meixell, G. E., Bristow, M. R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000094733.61689.d4 · Cited by 114
Characterization of Angiotensin-(1-7) in the Urine of Normal and Essential Hypertensive Subjects
Ferrario, C. M. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00400-7 · Cited by 114
Angiotensin-(1-7) and Its Effects in the Kidney
Dilauro, M., & Burns, K. D. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.70 · Cited by 114
Differential actions of renal ischemic injury on the intrarenal angiotensin system
Allred, A. J., Chappell, M. C., Ferrario, C. M., & Diz, D. I. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f636 · Cited by 113
Ferreira, A. J., Shenoy, V., Qi, Y., Fraga-Silva, R. A., Santos, R. A. S., Katovich, M. J., & Raizada, M. K. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2010.055277 · Cited by 112
Self-citationEvidence for an intrinsic angiotensin system in the canine pancreas
Chappell, M. C., Millsted, A., Diz, D. I., Brosnihan, K. B., & Ferrario, C. M. (1991) · Journal of Hypertension · doi:10.1097/00004872-199108000-00008 · Cited by 110
Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
Santos, R. A. S., Silva, A. C. S. E., Magaldi, A. J., et al. (1996) · Hypertension · doi:10.1161/01.hyp.27.4.875 · Cited by 110
Self-citationFaria-Silva, R., Duarte, F. V., & Santos, R. A. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000174594.17052.33 · Cited by 108
Self-citationAngiotensin (1???7) is an antagonist at the type 1 angiotensin II receptor
Mahon, J. M., Carr, R. D., Nicol, A. K., & Henderson, I. W. (1994) · Journal of Hypertension · doi:10.1097/00004872-199412000-00010 · Cited by 106
Tom, B., VRIES, R. D., Saxena, P. R., & Danser, A. H. J. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.95 · Cited by 105
Liu, C., Lv, X.-H., Li, H., Cao, X., Zhang, F., Wang, L., Mei, Y., & Yang, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0348-z · Cited by 104
Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7)
Leyen, S. A., Romero, M. F., Khosla, M. C., et al. (1993) · Kidney International · doi:10.1038/ki.1993.334 · Cited by 101
Angiotensin 1–7 Induces Bradykinin-Mediated Relaxation in Porcine Coronary Artery
Gorelik, G. J., Carbini, L. A., & Scicli, A. G. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37600-1 · Cited by 100
Expression and localization of the renin-angiotensin system in the rat pancreas
Leung, P. S., Chan, W., Wong, T. P., & Sernia, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600013 · Cited by 99
Characterization of a New Selective Antagonist for Angiotensin-(1–7), d -Pro 7 -Angiotensin-(1–7)
Santos, R. A. S., Haibara, A. S., Campagnole‐Santos, M. J., Silva, A. C. S. E., de Paula, R. D., Pinheiro, S. V. B., Leite, M. F., Lemos, V. S., Silva, D. M. R., Guerra, M. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000052947.60363.24 · Cited by 98
Self-citationPhysiology of the (pro)renin receptor: Wnt of change?
Sihn, G., Rousselle, A., Vilianovich, L., Burcklé, C., & Bäder, M. (2010) · Kidney International · doi:10.1038/ki.2010.151 · Cited by 96
Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
Clark, M. A., Diz, D. I., & Tallant, E. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1141 · Cited by 96
Canals, M., Jenkins, L., Kellett, E., & Milligan, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601121200 · Cited by 94
Angiotensin-(1-7) and the Rat Aorta: Modulation by the Endothelium
le Tran, Y., & Förster, C. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199711000-00019 · Cited by 93
Campbell, D. J., Zeitz, C. J., Esler, M., & Horowitz, J. D. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00020 · Cited by 88
Moon, J.-Y., Tanimoto, M., Gohda, T., Hagiwara, S., Yamazaki, T., Ohara, I., Murakoshi, M., Aoki, T., Ishikawa, Y., Lee, S.-H., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00065.2010 · Cited by 88
Almeida, A. P., Frábregas, B. C., Madureira, M. M., et al. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000600012 · Cited by 88
Lupi, R., Guerra, S. D., Bugliani, M., Boggi, U., Mosca, F., Torri, S., Prato, S. D., & Marchetti, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02086 · Cited by 87
Verano‐Braga, T., Schwämmle, V., Sylvester, M., Passos-Silva, D. G., Peluso, A. A., Etelvino, G. M., Santos, R. A. S., & Roepstorff, P. (2012) · Journal of Proteome Research · doi:10.1021/pr3001755 · Cited by 87
Self-citationJoyner, J., Neves, L. A. A., Granger, J. P., Alexander, B. T., Merrill, D., Chappell, M. C., Ferrario, C. M., Davis, W. P., & Brosnihan, K. B. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00387.2006 · Cited by 86
Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts
Ferreira, A. J., Santos, R. A. S., & Almeida, A. P. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000900009 · Cited by 84
Self-citationLima, C. V., de Paula, R. D., Resende, F. L., Khosla, M. C., & Santos, R. A. S. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.542 · Cited by 84
Self-citationJin, H., Song, B., Oudit, G. Y., Davidge, S. T., Yu, H., Jiang, Y., Gao, P., Zhu, D., Ning, G., Kassiri, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038502 · Cited by 83
Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
Gironacci, M. M., Adler‐Graschinsky, E., Peña, C., & Enero, M. A. (1994) · Hypertension · doi:10.1161/01.hyp.24.4.457 · Cited by 83
Pathways of angiotensin‐(1–7) metabolism in the kidney
Chappell, M. C., Allred, A. J., & Ferrario, C. M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.22 · Cited by 83
Nuclear angiotensin-(1–7) receptor is functionally coupled to the formation of nitric oxide
Gwathmey, T. M., Westwood, B. M., Pirro, N. T., Tang, L., Rose, J. C., Diz, D. I., & Chappell, M. C. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2010 · Cited by 83
Flow-Dependent Dilation Mediated by Endogenous Kinins Requires Angiotensin AT 2 Receptors
Bergaya, S., Hilgers, R. H. P., Meneton, P., Broquères-You, D., Bloch-Faure, M., Inagami, T., Alhenc‐Gelas, F., Levy, B. I., & Boulanger, C. M. (2004) · Circulation Research · doi:10.1161/01.res.0000131497.73744.1a · Cited by 81
Angiotensin-(1–7) attenuates diabetic nephropathy in Zucker diabetic fatty rats
Giani, J. F., Burghi, V., Veiras, L. C., Tomat, A. L., Muñoz, M. C., Cao, G., Turyn, D., Toblli, J. E., & Dominici, F. P. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00063.2012 · Cited by 80
Iyer, S. N., Yamada, K., Diz, D. I., Ferrario, C. M., & Chappell, M. C. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200007000-00015 · Cited by 79
Zhang, J., Noble, N. A., Border, W. A., & Huang, Y. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00548.2009 · Cited by 79
Murça, T. M., Moraes, P. L., Capuruço, C. A., Santos, S. H. S., Melo, M. B., Santos, R. A. S., Shenoy, V., Katovich, M. J., Raizada, M. K., & Ferreira, A. J. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.05.093 · Cited by 77
Self-citationSouza, A. M. D., Lopes, A. G., Pizzino, C. P., Fossari, R. N., Miguel, N. C. O., Cardozo, F. P., Abi-Abib, R. D. C., Fernandes, M. S., Santos, D. P. A., & Caruso‐Neves, C. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.005 · Cited by 74
Burns, W. C., Velkoska, E., Dean, R. G., Burrell, L. M., & Thomas, M. C. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00538.2009 · Cited by 74
Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. J., & Burrell, L. M. (2010) · Clinical Science · doi:10.1042/cs20100280 · Cited by 73
Giani, J. F., Muñoz, M. C., Pons, R. A., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00278.2010 · Cited by 73
Lara, L. S., Cavalcante, F., Axelband, F., Souza, A. M. D., Lopes, A. G., & Caruso‐Neves, C. (2006) · Biochemical Journal · doi:10.1042/bj20051455 · Cited by 72
Angiotensin-(1–7) binding at angiotensin II receptors in the rat brain
Rowe, B. P., Saylor, D. L., Speth, R. C., & Absher, D. R. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00010-9 · Cited by 72
Sasaki, S., Higashi, Y., Nakagawa, K., Matsuura, H., Kajiyama, G., & Oshima, T. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.90 · Cited by 69
Santos, G. A. B., Sampaio, W. O., Reudelhuber, T. L., Bäder, M., Campagnole‐Santos, M. J., & Santos, R. A. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01245.2006 · Cited by 69
Self-citationAmbühl, P., Felix, D., & Khosla, M. C. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90103-1 · Cited by 67
Marques, F. D., Melo, M. B., de Souza, L. E., Irigoyen, M. C., Sinisterra, R. D., Sousa, F. B. D., Savergnini, S. Q., Braga, V. B. A., Ferreira, A. J., & Santos, R. A. S. (2012) · International Journal of Hypertension · doi:10.1155/2012/795452 · Cited by 67
Self-citationAkhtar, S., Yousif, M. H. M., Dhaunsi, G. S., Chandrasekhar, B., Al‐Farsi, O., & Benter, I. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01613.x · Cited by 66
Davie, A. P., & McMurray, J. J. V. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.457 · Cited by 66
Garabelli, P. J., Modrall, J. G., Penninger, J. M., Ferrario, C. M., & Chappell, M. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040246 · Cited by 66
Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J., & Scholey, J. W. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00455.2011 · Cited by 66
Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents
Leung, P. S., Chan, H. C., Fu, L.-X., & Wong, P. Y. D. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1530269 · Cited by 65
Barroso, L. C., da Silveira, K. D., Lima, C. X., Borges, V. O., Bäder, M., Rachid, M. A., Santos, R. A. S., Souza, D. G., Silva, A. C. S. E., & Teixeira, M. M. (2012) · International Journal of Hypertension · doi:10.1155/2012/808726 · Cited by 65
Self-citationMass spectrometry for the molecular imaging of angiotensin metabolism in kidney
Grobe, N., Elased, K. M., Cool, D. R., & Morris, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00515.2011 · Cited by 65
Ferreira, A. J., de Oliveira, T. L., Castro, M., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.022 · Cited by 63
Self-citationMello, W. C. D. (2004) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2004.041 · Cited by 63
The renin-angiotensin system during acute myocardial ischemia in dogs.
Santos, R. A. S., Brum, J. M., Brosnihan, K. B., & Ferrario, C. M. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i121 · Cited by 62
Self-citationEffect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts
Neves, L. A. A., Almeida, A. P., Khosla, M. C., et al. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000600016 · Cited by 60
Angiotensin-(1–7) binds at the type 1 angiotensin II receptors in rat renal cortex
Gironacci, M. M., Coba, M. P., & Peña, C. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00067-1 · Cited by 60
The myocardial renin-angiotensin system: Existence, importance, and clinical implications
Grinstead, W. C., & Young, J. B. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90715-8 · Cited by 59
Angiotensin-(1-7) is a potent antidiuretic peptide in rats.
Santos, R. A. S., & Baracho, N. C. V. (1992) · PubMed · Cited by 58
Self-citationStegbauer, J., Potthoff, S. A., Quack, I., Mergia, E., Clasen, T., Friedrich, S., Vonend, O., Woznowski, M., Königshausen, E., Sellin, L. K., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01295.x · Cited by 56
Ferreira, A. J., Castro, C. H., Guatimosim, S., et al. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709353426 · Cited by 56
Self-citationMetabolism of angiotensin I in isolated rat hearts
Neves, L. A. A., Almeida, A. P., Khosla, M. C., & Santos, R. A. S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02049-7 · Cited by 56
Self-citationChronic infusion of angiotensin-(1–7) reduces heart angiotensin II levels in rats
Mendes, A. C. R., Ferreira, A. J., Pinheiro, S. V. B., & Santos, R. A. S. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.023 · Cited by 55
Self-citationFunctional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene
dos Santos, E. L., Reis, R. I., Silva, R. G., Shimuta, S. I., Pécher, C., Bascands, J., Schanstra, J. P., Oliveira, L., Bäder, M., Paiva, A. C. M., et al. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.030 · Cited by 54
Products of Angiotensin I Hydrolysis by Human Cardiac Enzymes Potentiate Bradykinin
Erdös, E. G., Jackman, H. L., Brovkovych, V. M., Tan, F., & Deddish, P. A. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2080 · Cited by 54
The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats
Collister, J. P., & Hendel, M. D. (2003) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2003.028 · Cited by 54
Munk, V. C., de Miguel, L. S., Petrimpol, M., Butz, N., Banfi, A., Eriksson, U., Hein, L., Humar, R., & Battegay, E. J. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.080242 · Cited by 54
Angiotensin-(1-7) Inhibits Angiotensin II–Induced Signal Transduction
Zhu, Z., Zhong, J., Zhu, S., Liu, D., van der Giet, M., & Tepel, M. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200211000-00007 · Cited by 54
Coêlho, M. S., Lopes, K. L., Freitas, R. R. D. A., Oliveira‐Sales, E. B., Bergamaschi, C. T., Campos, R. R., Casarini, D. E., Carmona, A. K., Araújo, M. S., Heimann, J. C., et al. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.03.008 · Cited by 53
Effect of Intratubular Application of Angiotensin 1-7 on Nephron Function
Vallon, V., Richter, K., Heyne, N., et al. (1997) · Kidney & Blood Pressure Research · doi:10.1159/000174151 · Cited by 53
Stegbauer, J. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.017 · Cited by 51
Angiotensin Converting Enzyme 2, Angiotensin‐(1‐7), and Receptor Mas Axis in the Kidney
Pinheiro, S. V. B., & Silva, A. C. S. E. (2012) · International Journal of Hypertension · doi:10.1155/2012/414128 · Cited by 50
Gava, E., Castro, C. H., Ferreira, A. J., Colleta, H. H. M. D., Melo, M. B., Alenina, N. V., Bäder, M., Oliveira, L. A. M., Santos, R. A. S., & Kitten, G. T. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.01.001 · Cited by 47
Self-citationFerreira, A. J., Bäder, M., & Santos, R. A. S. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.682572 · Cited by 46
Self-citationRakušan, D., Bürgelová, M., Vaněčková, I., et al. (2010) · Kidney & Blood Pressure Research · doi:10.1159/000320689 · Cited by 45
Bürgelová, M., Kramer, H. J., Teplan, V., Veličková, G., Vitko, S., Heller, J., Malý, J., & Červenka, L. (2002) · Kidney & Blood Pressure Research · doi:10.1159/000066340 · Cited by 44
Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm
Wilsdorf, T., Gainer, J. V., Murphey, L. J., Vaughan, D. E., & Brown, N. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1136 · Cited by 44
Angiotensin-(1–7) Antagonist A-779 Attenuates the Potentiation of Bradykinin by Captopril in Rats
Maia, L. G., Ramos, M. C., Fernandes, L., de Carvalho, M. H. C., Campagnole‐Santos, M. J., & Santos, R. A. S. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200405000-00011 · Cited by 43
Self-citationRenal actions of angiotensin-(1-7)
Silva, A. C. S. E., Baracho, N. C. D. V., Passaglio, K. T., & Santos, R. A. S. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000400012 · Cited by 43
Self-citationAngiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NOPreprint
Albrecht, D. (2007) · Learning & Memory · doi:10.1101/lm.425907 · Cited by 41
Joyner, J., Neves, L. A. A., Stovall, K., Ferrario, C. M., & Brosnihan, K. B. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00572.2007 · Cited by 41
Murugan, D. D., Mustafa, M. R., Achike, F. I., & Sim, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.037 · Cited by 40
Zhou, L., Xue, H., Wang, Z., Ni, J., Yao, T., Huang, Y., Yu, C., & Lü, L. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.12.015 · Cited by 39
Stanziola, L. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00090-4 · Cited by 38
Cited by
Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 602
COVID-19 cytokine storm: the anger of inflammation
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155151 · Cited by 461
Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
Gallo, G., Volpe, M., & Savoia, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798958 · Cited by 446
“Experimental studies suggest that also the activation of ACE-2/Ang (1–7)/MasR axis may in part counteract the Ang II–induced actions in the cardiovascular system, including endothelial dysfunction, vasoconstriction and cell growth (53).”
BackgroundLi, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., Liu, F. F., Zhang, K., & Zhang, C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.59 · Cited by 426
Metadata
- Authors
- Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2012-10-22
- Volume
- 216
- Issue
- 2
- Pages
- R1-R17
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2112443030
- Cited by
- 523
- References
- 209
- FWCI
- 24.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.